Flere firmaers patenter er i farezonen efter omstridt EU-dom: Selskaber, der har fået patent på forskning med visse stamceller, risikerer at komme til at stå med et ugyldigt patent i hånden
Press/Media: Press / Media
22/03/2012
A web-based newspaper specialized on Biotech, Medicine & Pharma
Based on my speeches during the stem cell symposium at Carlberg Akademi (21.03.12) I gave an interview and provided input concerning the CJEU's decision in Brüstle. I was cited several times in the article.
Based on my speeches during the stem cell symposium at Carlberg Akademi (21.03.12) I gave an interview and provided input concerning the CJEU's decision in Brüstle. I was cited several times in the article.
References
Flere firmaers patenter er i farezonen efter omstridt EU-dom: Selskaber, der har fået patent på forskning med visse stamceller, risikerer at komme til at stå med et ugyldigt patent i hånden
JP/Politikens Hus 2011, 1 h
MedWatch
http://medwatch.dk/secure/Medicinal___Biotek/article3005541.ece
ID: 175195014